Fully automated fast-flow synthesis of antisense phosphorodiamidate morpholino oligomers

Rapid development of antisense therapies can enable on-demand responses to new viral pathogens and make personalized medicine for genetic diseases practical. Antisense phosphorodiamidate morpholino oligomers (PMOs) are promising candidates to fill such a role, but their challenging synthesis limits...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Chengxi, Callahan, Alex J., Simon, Mark D., Totaro, Kyle A., Mijalis, Alexander J., Phadke, Kruttika-Suhas, Zhang, Genwei, Hartrampf, Nina, Schissel, Carly K., Zhou, Ming, Zong, Hong, Hanson, Gunnar J., Loas, Andrei, Pohl, Nicola L. B., Verhoeven, David E., Pentelute, Bradley L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8292409/
https://www.ncbi.nlm.nih.gov/pubmed/34285203
http://dx.doi.org/10.1038/s41467-021-24598-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8292409/
https://www.ncbi.nlm.nih.gov/pubmed/34285203
http://dx.doi.org/10.1038/s41467-021-24598-4

Ejemplares similares